TherapeuticsMD (TXMD) Assets Average (2011 - 2026)

TherapeuticsMD has reported Assets Average for 15 years, with the latest figure at $37.6 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 2.36% year-over-year to $37.6 million; the trailing twelve-month figure through Mar 2026 stood at $37.6 million (down 2.36% YoY), and the FY2025 full-year result was $38.2 million, down 6.88% from the prior year.
• Assets Average for Q1 2026 stood at $37.6 million, down from $38.2 million in the prior quarter.
• The five-year high for Assets Average was $151.4 million in Q1 2022, with the low at $37.6 million in Q1 2026.
• Historically, Assets Average has averaged $66.4 million across 5 years, with a median of $42.7 million in 2024.
• Annual changes were most pronounced in 2023 — Assets Average sank 62.81% — and 2026, when it decreased 2.36%.
• TherapeuticsMD's Assets Average stood at $112.2 million in 2022, then tumbled by 58.19% to $46.9 million in 2023, then slipped by 16.45% to $39.2 million in 2024, then decreased by 2.61% to $38.2 million in 2025, then declined by 1.43% to $37.6 million in 2026.
• The last three Assets Average figures came in at $37.6 million (Q1 2026), $38.2 million (Q4 2025), and $38.6 million (Q3 2025), per Business Quant data.